🔎 Trials Near Me

Home › Sickle Cell Disease › NCT06385886

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

RecruitingObservational study

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Persons must be \>/= 18 years of age
* Persons must have confirmed SCD
* Persons not seen by a SCD specialist \> 1 year +/- 3 months
* Literacy in English will be required of the consenting patient or parent/guardian

Exclusion Criteria:

* Persons \< 18 years of age
* Persons that are unable to provide informed consent and do not have a designated care-giver that can consent on his/her behalf
* Persons with sickle cell trait (as per hemoglobin electrophoresis)
* Persons seen by a SCD specialist \< 1 year +/1 3 months

About the study

The goal of this observational study is to help us understand more about the best ways to help individuals living with Sickle Cell Disease (SCD) get the best care. The main question it aims to answer is: How to find individuals unaffiliated from SCD specialist care use three distinct pathways? Once unaffiliated individuals are found using the pathways, Investigators will employ linkage coordinators (trained staff) to engage these patients in care. Participants will be asked to fill out an assessment survey which will cover areas such as previous and current treatment, clinic and hospital experience, pain, and quality of life. Participants will also be given the option of participation in a 1-hour long interview how they feel about treatment for sickle cell disease including clinic experience, pain, and quality of life?

What is being tested

Sponsor: RTI International · Participants: 500 · Started: Jun 8, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT06385886

Locations in the U.S.

AlabamaUniversity of Alabama, Birmingham (UAB), Birmingham
ArizonaPhoenix Children's Hospital, Phoenix
CaliforniaUniversity of California, San Francisco (UCSF), Oakland
GeorgiaAugusta University, Augusta
IllinoisUniversity of Illinois, Chicago
OhioCleveland Clinic, Cleveland
PennsylvaniaUniversity of Pennsylvania, Philadelphia
TennesseeUniversity of Tennessee at Memphis, Memphis
TexasUniversity of Texas at Houston, Houston

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.